Author Archives: Liz Seegert

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

Report examines senior living facilities in the wake of COVID-19

socially distanced residents in front of their retirement home

Photo: Gilbert Mercier via Flickr

The devastating toll of the coronavirus pandemic in nursing homes has had a domino effect on the entire senior living industry, according to a new report. Misconceptions about housing for older adults, along with negative perceptions about assisted living, independent living and active adult communities, have prompted many owners and operators to take a hard look at what this industry must do to reassure residents and families about safety and wellness. Continue reading

What Trump’s drug manufacturing order may mean for seniors

Photo: fauxto_digit via Flickr

President Trump’s recent executive order, which mandates certain government agencies to “buy American” drugs and medical equipment, is setting up a potential clash with the powerful drug manufacturers’ lobby.

The order, issued August 6, would require agencies like the Department of Veterans Affairs or Department of Health and Human Services to procure domestically produced drugs and medical supplies to help mitigate shortages and difficulty obtaining certain medications from overseas suppliers. Continue reading

High BMI, other health factors when young may increase later risk for Alzheimer’s disease

Poor cardiovascular health and a high body mass index during a person’s teens and 20s may be early predictors for developing Alzheimer’s disease later in life, according to research presented last week at the Alzheimer’s Association International Conference.

The research, presented in a virtual poster session, demonstrates the importance of preventive efforts at a younger age, especially among African Americans disproportionally affected by high blood pressure, high cholesterol, diabetes and similar conditions. Continue reading

Nursing homes get more financial help, must test more often

Photo: michael_swan via Flickr

U.S. nursing homes that participate in Medicare and Medicaid will be getting a $5 billion infusion of “provider relief funds” from the Department of Health and Human Services, President Trump announced on July 22. The funds are meant to help with testing, purchasing personal protective equipment and hiring additional staff.

Nursing homes in “hot spots” like Florida, Texas, and California will be at the top of the list, according to The Seattle Times. The funding package also includes the distribution of additional rapid point-of-care diagnostic testing devices. The Center for Medicare and Medicaid Services also will begin requiring, rather than just recommending, that all nursing homes in states with a 5% positivity rate or higher test all nursing home staff each week. This new staff testing requirement is designed to better keep the virus from entering and spreading through nursing homes by identifying asymptomatic carriers. Continue reading

Food insecurity a growing issue for seniors, compounded by pandemic


Photo: Ross Pollack via Flickr

While people in parts of the U.S. slowly return to work and leisure activities, food insecurity remains a serious issue for many Americans, according to a June Census Bureau analysis. It’s an especially concerning problem for older Americans, who may still be hesitant to leave their homes to go grocery shopping, especially if they must rely on public transportation

The pandemic has worsened the problem of food insecurity among older adults. Feeding America’s most recent report found that that 5.3 million seniors, or 7.3% of the senior population, were food insecure in 2018.  In the wake of COVID-19, they estimate that some 54 million Americans of all ages may face hunger in 2020. Continue reading

Biogen submits BLA for an Alzheimer’s drug with a controversial past

Photo: GollyGforce via Flickr

Could an Alzheimer’s drug finally be on the horizon? Possibly ― if the FDA agrees with data from several Biogen clinical trials ― but approval is still far from a sure bet.

The company, on July 9, submitted its biologics license application (BLA) for aducanumab, an investigational treatment for the disease. The submission includes clinical data from Phase 3 EMERGE and ENGAGE studies, as well as the Phase 1B PRIME study. Biogen has requested an accelerated review, potentially putting the medication on a path for a final decision by March 2021. However, data from these Phase 3 trials are not without controversy in the scientific community.

“Aducanumab, a so-called monoclonal antibody designed to target amyloid plaque in the brain, has been one of the most closely watched drugs in development for several years,” according to Bloomberg News. Continue reading